Fungal Metabolites as Multi-Target Modulators of Alzheimer’s Disease: An Integrated In Silico Docking and Molecular Dynamics Approach

Deepeesh Vijayan; Karthick Siva; Jayathraa Ramachandran; Durai Saravanan

doi:10.55230/mabjournal.v55i3.3751

Authors

Deepeesh Vijayan Department of Radio Diagnosis, Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry – 605006, India
Karthick Siva Accelerd Sciences Private Limited, Chennai 600 048.3
Jayathraa Ramachandran Accelerd Sciences Private Limited, Chennai 600 048
Durai Saravanan
snegamsaran@gmail.com
Saveetha College of Physiotherapy, Saveetha Institute of Medical and Technical Sciences, Chennai −601205, Tamil Nadu, India.

Keywords:

Alzheimer’s disease, fungal metabolites, in silico, molecular docking, molecular dynamics simulation, neuroprotection

Abstract

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder with limited therapeutic options offering only symptomatic relief. Natural fungal metabolites have recently gained attention for their neuroprotective potential. In this study, an extensive library of 18,349 fungal compounds was retrieved from the NPAtlas database and systematically screened for drug-likeness, ADMET properties, and toxicity profiles. Successive filtering reduced the dataset to 99 drug-like molecules, of which five candidates—Sonomolide A, Steperoxide A, RP-1551-M2, Illudin J, and Pericoannosin F—were selected for detailed analysis. These compounds demonstrated favourable physicochemical properties, compliance with Lipinski’s Rule of Five, high gastrointestinal absorption, blood–brain barrier permeability, and acceptable toxicity margins (Class 6). Molecular docking against five AD-related targets (AChE, CBNR2, CHRM1, CHRM4, & D1B dopamine receptor) revealed strong binding affinities, with Steperoxide A showing the highest affinity for AChE (−8.0 kcaL/moL) and CBNR2 (−9.0 kcaL/moL), while RP-1551-M2 displayed consistent interactions with muscarinic and dopamine receptors. MD simulations confirmed stable protein–ligand interactions, with RMSD values ranging from 0.10–1.75 nm and hydrogen-bond counts between 47–252 throughout the trajectory. Stable radius of gyration values (2.74–3.95 nm) further indicated the maintenance of structural compactness and binding integrity, and the results also showed good stability and favourable interaction profiles. Collectively, these findings highlight fungal metabolites—particularly Steperoxide A and RP-1551-M2—as promising multi-target neuroprotective scaffolds with potential therapeutic relevance in AD.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Amo, L. Del, Cano, A., Ettcheto, M., Souto, E.B., Espina, M., Camins, A., Garcia, M.L. & Sánchez-López, E. 2021. Surface functionalization of PLGA nanoparticles to increase transport across the BBB for Alzheimer's disease. Applied Sciences, 11(9): 4305. DOI: https://doi.org/10.3390/app11094305

An, H.-J., Jeong, H.-J., Um, J.-Y., Kim, H.-M. & Hong, S.-H. 2006. Glechoma hederacea inhibits inflammatory mediator release in IFN-γ and LPS-stimulated mouse peritoneal macrophages. Journal of Ethnopharmacology, 106(3): 418-424. DOI: https://doi.org/10.1016/j.jep.2006.01.024

Apostolova, L.G. 2016. Alzheimer disease. Continuum (Minneap Minn), 22: 419-434. DOI: https://doi.org/10.1212/CON.0000000000000307

Armstrong, R. 2020. What causes neurodegenerative disease? Folia Neuropathologica, 58(2): 93-112. DOI: https://doi.org/10.5114/fn.2020.96707

Azhari, A. & Supratman, U. 2021. The chemistry and pharmacology of fungal genus Periconia: A review. Scientia Pharmaceutica, 89(3): 34. DOI: https://doi.org/10.3390/scipharm89030034

Bains, A., Chawla, P., Kaur, S., Najda, A., Fogarasi, M. & Fogarasi, S. 2021. Bioactives from mushroom: Health attributes and food industry applications. Materials, 14(24): 7640. DOI: https://doi.org/10.3390/ma14247640

Banerjee, P., Kemmler, E., Dunkel, M. & Preissner, R. 2024. ProTox 3.0: A webserver for the prediction of toxicity of chemicals. Nucleic Acids Research, 52(W1): W513-W520. DOI: https://doi.org/10.1093/nar/gkae303

Breijyeh, Z. & Karaman, R. 2020. Comprehensive review on Alzheimer's disease: Causes and treatment. Molecules, 25(24): 5789. DOI: https://doi.org/10.3390/molecules25245789

Castellani, R.J., Rolston, R.K. & Smith, M.A. 2010. Alzheimer disease. Disease-a-Month, 56(9): 484-546. DOI: https://doi.org/10.1016/j.disamonth.2010.06.001

Cristino, L., Bisogno, T. & Di Marzo, V. 2020. Cannabinoids and the expanded endocannabinoid system in neurological disorders. Nature Reviews Neurology, 16(1): 9-29. DOI: https://doi.org/10.1038/s41582-019-0284-z

Dasgupta, A. & Acharya, K. 2019. Mushrooms: An emerging resource for therapeutic terpenoids. 3 Biotech, 9(10): 369. DOI: https://doi.org/10.1007/s13205-019-1906-2

Fernandes, T.B., Segretti, M.C.F., Polli, M.C. & Parise-Filho, R. 2016. Analysis of the applicability and use of Lipinski's rule for central nervous system drugs. Letters in Drug Design & Discovery, 13(10): 999-1006. DOI: https://doi.org/10.2174/1570180813666160622092839

Gonzalez Del Val, A., Platas, G., Arenal, F., Orihuela, J.C., Garcia, M., Hernandez, P., Royo, L., De Pedro, N., Silver, L.L., Young, K., Vicente, M.F. & Pelaez, F. 2003. Novel illudins from Coprinopsis episcopalis (syn. Coprinus episcopalis), and the distribution of illudin-like compounds among filamentous fungi. Mycological Research, 107(10): 1201-1209. DOI: https://doi.org/10.1017/S0953756203008487

Grabski, H. & Tiratsuyan, S. 2018. Mechanistic insights of the attenuation of quorum-sensing-dependent virulence factors of Pseudomonas aeruginosa: Molecular modeling of the interaction of taxifolin with transcriptional regulator LasR. bioRxiv: 500157. DOI: https://doi.org/10.1101/500157

Habtemariam, S. 2019. Natural products in Alzheimer's disease therapy: Would old therapeutic approaches fix the broken promise of modern medicines? Molecules, 24(8): 1519. DOI: https://doi.org/10.3390/molecules24081519

Hasan, G.M., Anwar, S., Shamsi, A., Sohal, S.S. & Hassan, M.I. 2024. The neuroprotective potential of phytochemicals in traumatic brain injury: mechanistic insights and pharmacological implications. Frontiers in Pharmacology, 14: 1330098. DOI: https://doi.org/10.3389/fphar.2023.1330098

Herrmann, N., Chau, S.A., Kircanski, L. & Lanctôt, K.L. 2011. Current and emerging drug treatment options for Alzheimer's disease. Drugs, 71(15): 2031-2065. DOI: https://doi.org/10.2165/11595870-000000000-00000

Hosen, M.I., Mia, M.E., Islam, M.N., Khatun, M.U.S., Emon, T.H., Hossain, M.A., Akter, F., Kader, M.A., Jeba, S.H., Faisal, A.S.M. et al. 2024. In-silico approach to characterize the structure and function of a hypothetical protein of Monkeypox virus exploring Chordopox-A20R domain-containing protein activity. Antiviral Therapy, 29(3): 13596535241255199. DOI: https://doi.org/10.1177/13596535241255199

Kawahata, I., Finkelstein, D.I. & Fukunaga, K. 2024. Dopamine D1-D5 receptors in brain nuclei: Implications for health and disease. Receptors, 3(2): 155-181. DOI: https://doi.org/10.3390/receptors3020009

Khaerunnisa, S., Kurniawan, H., Awaluddin, R., Suhartati, S., Soetjipto, S. et al. 2020. Potential inhibitor of COVID-19 main protease (Mpro) from several medicinal plant compounds by molecular docking study. Preprints, 2020: 2020030226. DOI: https://doi.org/10.20944/preprints202003.0226.v1

Khodja, E.A.T., Bensaad, M.S., Benslama, O., Khabtane, A.E.H., Arhab, R., Bensouici, C., Baty, R.S., Sami, R., Alanazi, M.A., Algehainy, N.A. et al. 2025. Chemical composition, antioxidant, and anti-Alzheimer potential of acetone extract of Tamarix africana seeds with docking approach: Cholinesterase enzymes. Clinical Laboratory, 71(8). DOI: https://doi.org/10.7754/Clin.Lab.2025.250115

Kovács, Z., Brunner, B. & Ari, C. 2021. Beneficial effects of exogenous ketogenic supplements on aging processes and age-related neurodegenerative diseases. Nutrients, 13(7): 2197. DOI: https://doi.org/10.3390/nu13072197

Liu, D.-Z., Dong, Z.-J., Wang, F. & Liu, J.-K. 2010. Two novel norsesquiterpene peroxides from basidiomycete Steccherinum ochraceum. Tetrahedron Letters, 51(23): 3152-3153. DOI: https://doi.org/10.1016/j.tetlet.2010.04.048

Liu, P.-P., Xie, Y., Meng, X.-Y. & Kang, J.-S. 2019. History and progress of hypotheses and clinical trials for Alzheimer's disease. Signal Transduction and Targeted Therapy, 4(1): 29. DOI: https://doi.org/10.1038/s41392-019-0063-8

Łysakowska, P., Sobota, A. & Wirkijowska, A. 2023. Medicinal mushrooms: Their bioactive components, nutritional value and application in functional food production a review. Molecules, 28(14): 5393. DOI: https://doi.org/10.3390/molecules28145393

McCormick, J.W., McCormick, L.A., Chen, G., Vogel, P.D. & Wise, J.G. 2021. Transport of Alzheimer's associated amyloid-β catalyzed by P-glycoprotein. PLoS One, 16(4): e0250371. DOI: https://doi.org/10.1371/journal.pone.0250371

McGirr, S. & V.C.S.A. 2020. Alzheimer's disease: A brief review. Journal of Experimental Neurology, 1(3). DOI: https://doi.org/10.33696/Neurol.1.015

Mohapatra, R.K., Mahal, A., Ansari, A., Kumar, M., Guru, J.P., Sarangi, A.K., Abdou, A., Mishra, S., Aljeldah, M., AlShehail, B.M. et al. 2023. Comparison of the binding energies of approved mpox drugs and phytochemicals through molecular docking, molecular dynamics simulation, and ADMET studies: an in silico approach. Journal of Biosafety and Biosecurity, 5(3): 118-132. DOI: https://doi.org/10.1016/j.jobb.2023.09.001

Morris, S.A., Curotto, J.E., Zink, D.L., Dreikorn, S., Jenkins, R., Bills, G.F., Thompson, J.R., Vicente, F., Basilio, A., Liesch, J.M. & Schwartz, R.E. 1995. Sonomolides A and B, new broad spectrum antifungal agents isolated from a coprophilous fungus. Tetrahedron Letters, 36(50): 9101-9104. DOI: https://doi.org/10.1016/0040-4039(95)01965-K

Murphy, M.P. & LeVine III, H. 2010. Alzheimer's disease and the amyloid-β peptide. Journal of Alzheimer's Disease, 19(1): 311-323. DOI: https://doi.org/10.3233/JAD-2010-1221

Pathan, N. & Shende, P. 2021. Tailoring of P-glycoprotein for effective transportation of actives across blood-brain-barrier. Journal of Controlled Release, 335: 398-407. DOI: https://doi.org/10.1016/j.jconrel.2021.05.046

Rahaman, M.S., Siraj, M.A., Sultana, S., Seidel, V. & Islam, M.A. 2020. Molecular phylogenetics and biological potential of fungal endophytes from plants of the sundarbans mangrove. Frontiers in Microbiology, 11. DOI: https://doi.org/10.3389/fmicb.2020.570855

Rajamanikandan, S., Jeyakanthan, J. & Srinivasan, P. 2017. Molecular docking, molecular dynamics simulations, computational screening to design quorum sensing inhibitors targeting LuxP of Vibrio harveyi and its biological evaluation. Applied Biochemistry and Biotechnology, 181: 192-218. DOI: https://doi.org/10.1007/s12010-016-2207-4

Rawat, K., Tewari, D., Bisht, A., Chandra, S., Tiruneh, Y.K., Hassan, H.M., Al-Emam, A., Sindi, E.R. & Al-Dies, A.-A.M. 2024. Identification of AChE targeted therapeutic compounds for Alzheimer's disease: an in-silico study with DFT integration. Scientific Reports, 14(1): 30356. DOI: https://doi.org/10.1038/s41598-024-81285-2

Reusch, N., Ravichandran, K.A., Olabiyi, B.F., Komorowska-Müller, J.A., Hansen, J.N., Ulas, T., Beyer, M., Zimmer, A. & Schmöle, A. 2022. Cannabinoid receptor 2 is necessary to induce toll-like receptor-mediated microglial activation. Glia, 70(1): 71-88. DOI: https://doi.org/10.1002/glia.24089

Rook, J., Choi, D., Foster, D. & Conn, P.J. 2014. Activation of M1 and M4 muscarinic receptors as potential treatments for Alzheimer's disease and schizophrenia. Neuropsychiatric Disease and Treatment, 183. DOI: https://doi.org/10.2147/NDT.S55104

Roy, K. (Ed.) 2023. Computational Modeling of Drugs Against Alzheimer's Disease. Vol. 203. Springer Nature, Singapore.

Saggu, S., Bai, A., Aida, M., Rehman, H., Pless, A., Ware, D., Deak, F., Jiao, K. & Wang, Q. 2024. Monoamine alterations in Alzheimer's disease and their implications in comorbid neuropsychiatric symptoms. GeroScience, 47(1): 457-482. DOI: https://doi.org/10.1007/s11357-024-01359-x

Scheiner, M., Dolles, D., Gunesch, S., Hoffmann, M., Nabissi, M., Marinelli, O., Naldi, M., Bartolini, M., Petralla, S., Poeta, E., Monti, B., Falkeis, C., Vieth, M., Hübner, H., Gmeiner, P., Maitra, R., Maurice, T. & Decker, M. 2019. Dual-acting cholinesterase-human cannabinoid receptor 2 ligands show pronounced neuroprotection in vitro and overadditive and disease-modifying neuroprotective effects in vivo. Journal of Medicinal Chemistry, 62(20): 9078-9102. DOI: https://doi.org/10.1021/acs.jmedchem.9b00623

Shen, B. 2015. A new golden age of natural products drug discovery. Cell, 163(6): 1297-1300. DOI: https://doi.org/10.1016/j.cell.2015.11.031

Toki, S., Tanaka, T., Uosaki, Y., Yoshida, M., Suzuki, Y., Kita, K., Mihara, A., Ando, K., Lokker, N.A., Giese, N.A. & Matsuda, Y. 1999. RP-1551s, a family of Azaphilones produced by Penicillium sp., inhibit the binding of PDGF to the extracellular domain of its receptor. The Journal of Antibiotics, 52(3): 235-244. DOI: https://doi.org/10.7164/antibiotics.52.235

Vijayakumar, S., Manogar, P., Prabhu, S. & Sanjeevkumar Singh, R.A. 2018. Novel ligand-based docking; molecular dynamic simulations; and absorption, distribution, metabolism, and excretion approach to analyzing potential acetylcholinesterase inhibitors for Alzheimer's disease. Journal of Pharmaceutical Analysis, 8(6): 413-420. DOI: https://doi.org/10.1016/j.jpha.2017.07.006

Wu, B., Ohlendorf, B., Oesker, V., Wiese, J., Malien, S., Schmaljohann, R. & Imhoff, J.F. 2015. Acetylcholinesterase inhibitors from a marine fungus Talaromyces sp. strain L.F458. Marine Biotechnology, 17: 110-119. DOI: https://doi.org/10.1007/s10126-014-9599-3

Zhang, D., Tao, X., Chen, R., Liu, J., Li, L., Fang, X., Yu, L. & Dai, J. 2015. Pericoannosin A, a polyketide synthase-nonribosomal peptide synthetase hybrid metabolite with new carbon skeleton from the endophytic fungus Periconia sp. Organic Letters, 17(17): 4304-4307. DOI: https://doi.org/10.1021/acs.orglett.5b02123

Zhang, M.-Q. & Wilkinson, B. 2007. Drug discovery beyond the "rule-of-five". Current Opinion in Biotechnology, 18(6): 478-488. DOI: https://doi.org/10.1016/j.copbio.2007.10.005

Zhao, J., Wang, M., Liu, W., Ma, Z. & Wu, J. 2020. Activation of cannabinoid receptor 2 protects rat hippocampal neurons against Aβ-induced neuronal toxicity. Neuroscience Letters, 735: 135207. DOI: https://doi.org/10.1016/j.neulet.2020.135207